Detection of Light Chain Restriction in non-Hodgkin Lymphoma by a Novel RNA In Si

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$268,010.00
Award Year:
2012
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA168019-01
Award Id:
n/a
Agency Tracking Number:
R43CA168019
Solicitation Year:
2012
Solicitation Topic Code:
NCI
Solicitation Number:
PA11-096
Small Business Information
3960 Point Eden Way, HAYWARD, CA, 94545
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
607435869
Principal Investigator:
XIAO-JUN MA
(510) 576-8800
xma@acdbio.com
Business Contact:
YULING LUO
(510) 576-8800
yluo@acdbio.com
Research Institution:
Stub




Abstract
DESCRIPTION (provided by applicant): Immunoglobulin (Ig) light chain restriction (LCR) detection is an important molecular diagnostic tool in the differential diagnosis that includes lymphoid hyperplasia, atypical lymphoid hyperplasia, chronic inflammation, and B cell neoplasms. Current methods of LCR identification in formalin fixed paraffin embedded (FFPE) tissue include immunohistochemistry (IHC) and conventional chromogenic in situ hybridization (CISH), which measure kappa or lambda protein and mRNA, respectively. However, both IHC and conventional CISH lack sufficient sensitivity to detect LCR in many non-Hodgkin lymphoma (NHL), including the most common NHL variants - follicular lymphoma, diffuse large B cell lymphoma, small B lymphocytic lymphoma, and extranodal marginal zone lymphoma of MALT type. RNAscope is novel RNA in situ hybridization technology that has single-molecule detection sensitivity and is fully compatible with FFPE tissue using either chromogenic or fluorescent detection. We hypothesize that RNAscope will accurately and reproducibly delineate LCR in all non-Hodgkin lymphoma types. We propose to develop an RNAscope-based CISH assay for kappa and lambda mRNAs for LCR detection in FFPE tissue. PUBLIC HEALTH RELEVANCE: The diagnosis of lymphoma can be difficult based on morphology alone. Detection of restricted immunoglobulin light chain expression is a molecular ancillary tool to resolve ambiguous lymphoproliferative disorders. The proposed product based on RNAscope willprovide superior sensitivity to current methods.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government